Sigma Planning Corp Has $558,000 Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sigma Planning Corp grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.9% during the third quarter, HoldingsChannel.com reports. The firm owned 5,950 shares of the company’s stock after purchasing an additional 330 shares during the period. Sigma Planning Corp’s holdings in GE HealthCare Technologies were worth $558,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in GEHC. Vanguard Group Inc. boosted its stake in shares of GE HealthCare Technologies by 9.2% during the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after purchasing an additional 4,107,746 shares in the last quarter. Capital Research Global Investors boosted its stake in shares of GE HealthCare Technologies by 5.2% during the first quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock valued at $4,908,406,000 after purchasing an additional 2,647,204 shares in the last quarter. Van ECK Associates Corp acquired a new stake in shares of GE HealthCare Technologies during the third quarter valued at about $208,513,000. Marshall Wace LLP acquired a new stake in shares of GE HealthCare Technologies during the second quarter valued at about $63,639,000. Finally, Jacobs Levy Equity Management Inc. lifted its stake in shares of GE HealthCare Technologies by 4,959.8% in the first quarter. Jacobs Levy Equity Management Inc. now owns 758,514 shares of the company’s stock worth $68,957,000 after acquiring an additional 743,523 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.27% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective on the stock. Stifel Nicolaus lifted their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday, September 18th. Finally, Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $94.36.

GE HealthCare Technologies Trading Down 1.5 %

NASDAQ GEHC opened at $82.92 on Friday. The company has a market cap of $37.88 billion, a price-to-earnings ratio of 22.78, a P/E/G ratio of 3.05 and a beta of 1.24. GE HealthCare Technologies Inc. has a 52 week low of $66.39 and a 52 week high of $94.55. The business has a 50 day moving average price of $88.76 and a 200-day moving average price of $83.48. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company’s quarterly revenue was up .9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.99 earnings per share. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is 3.30%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.